Covance’s Chandler site OKed by AAALAC
Covance’s animal testing facility in Chandler, Arizona has been fully accredited by the AAALAC with no recommendations for improvement.
Korsch and ACG set up tabletting machine JV
German compression technology specialist Korsch says its JV with ACG Worldwide (ACG) helps meet growing global demand for tabletting machines.
Finished dosage growth helps Granules’ Q2
Increased focus on international markets, soaring demand for finished dosage forms and improved capacity usage helped India-based CMO Granules posting record revenues.
PRA adds Milan office as Italian research spending grows
PRA International has opened a new office in Milan, Italy, boosting visibility in the country’s competitive contract trials sector.
Hovione adds aseptic spray drying to offering
Portuguese CMO Hovione has bought an aseptic spray-drying line from US firm Acusphere and says that the demand for the technology is increasing as drug firms aim to boost bioavailability.
Novavax increasing H1N1 vaccine production
Novavax has entered into a deal with Xcellerex to boost production of its H1N1 vaccine, which is entering clinical trials in Mexico, using the CMO’s FlexFactory disposable biomanufacturing platform.
2D barcodes make faking less attractive, says EFPIA
The EFPIA hopes a pilot 2D barcode labelling scheme will make drug counterfeiting less attractive for fakers and help improve patient safety.
Appointments at WuXi PharmaTech, Sundia, CMC Biologics and Xoma – People on the move
Outsourcing-Pharma presents its latest round of movements in the pharma outsourcing sector, including appointments at WuXi PharmaTech, Sundia, CMC Biologics and Xoma.
“Tremendous scrutiny” of trials affects insurance; MD
Globalisation and “heightened awareness and scrutiny of clinical trials” in the wake of the Northwick Park, UK incident, where some patients suffered multiple organ failure, have had a significant impact on study insurance, according to a MD.
US doctors say drug labels lack key information
Drug labelling approved by the US FDA often lack key information, according to two physicians quoted in the New England Journal of Medicine (NEJM).
The CRO results season is underway with Icon and Covance both posting mixed Q3 figures as the challenges facing pharma, and businesses in general, continue to impact on operations.
GEA launches contract spray-drying service
GEA Niro has begun offering contract spray-drying services for drug candidates and clinical trial supplies from its “Test Center” in Copenhagen, Denmark and wants the drug industry to know about the technique’s advantages.
Soluplus launched as market for HME excipients heats up
BASF says its new Soluplus excipient will help meet demand for solubilising agents that are compatible with hot melt extrusion (HME) manufacturing methods.
CER is a “historical market opportunity”; Quintiles VP
Comparative effectiveness research (CER) represents a “historical market opportunity”, according to a VP at Quintiles who explained that pharmas that do the work will be “properly rewarded for their innovations”.
Health Decisions franchises to globalise
Health Decisions is “effectively franchising” its clinical trial model to other CROs to create a network of partners that it believes will offer “great flexibility” to clients, according to its COO.